The latest CDC numbers show a 5.0% increase of measles cases from week-to-week. The US total reached 4080 confirmed cases, 78% above all of 2025.
|Articles|August 24, 2020
First COVID-19 Reinfection Case Observed in Hong Kong
Author(s)Kevin Kunzmann
Investigators observed a second set of virus in a previously infected 33-year-old man, nearly 5 months after his first positive COVID-19 case.
Advertisement
The first confirmed reinfection case of
In a report from The New York Times Monday morning, investigators in China stated a 33-year-old man with mild COVID-19 symptoms during a prior infection is again confirmed to have the virus—only now in asymptomatic form.
The evidenced reinfection comes on the heels of US Centers for Disease Control and Prevention (CDC)
The guidance was issued after published investigations varied on the conclusion that infected persons had approximate three-month COVID-19 immunity with developed antibodies.
The new reinfection patient, deemed “apparently young and healthy” by University of Hong Kong investigators in a statement, was first infected with COVID-19 more than 4 months ago.
His reinfection was reported following a trip to Spain, with a second set of virus being closely matched to a COVID-19 strain common in Europe during the last 2 months.
“Our results prove that his second infection is caused by a new virus that he acquired recently rather than prolonged viral shedding,” Kelvin Kai-Wang To, MD, a clinical microbiologist at the University of Hong Kong, said in the statement.
Advertisement
Related to this article
With US measles cases nearing 3,900 this year and Pennsylvania reporting its fifth measles-related death, here is a review of how the virus spreads, how it is prevented and managed, and what severe disease looks like.
Vaxcyte's 31-valent pneumococcal conjugate vaccine candidate met every prespecified primary immunogenicity and safety endpoint against PCV20 and PCV21 in the OPUS-1 trial of 4,047 US adults.
Irkutsk anti-plague institute death prompts quarantines and conflicting official accounts.
A laboratory technician at a Siberian anti-plague institute has died of pneumonia of unknown cause, prompting quarantines and contact monitoring while Russian officials stop short of confirming plague.
A study finding clesrovimab comparable to palivizumab in protecting at-risk infants in their first RSV season was extended to demonstrate clesrovimab effective and well-tolerated when administered in their second season.
In the phase 3 LIBERTY study, the investigational monoclonal antibody, VYD2311, had significantly fewer adverse events than an mRNA COVID-19 vaccine, and it did not blunt vaccine-induced neutralizing titers when the two were given together.
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.